Hikma Pharmaceuticals Appoints Ex-US Industry Body Chief To Board

Mon, 22nd Feb 2016 09:58

LONDON (Alliance News) - Drug company Hikma Pharmaceuticals PLC on Monday said it has appointed John Castellani as an independent non-executive director.

Castellani will join on March 1 and is the former president and chief executive of Pharmaceutical Research & Manufacturers of America, a US pharmaceutical industry trade body.

Hikma shares were up 3.0% to 1,929.00 pence on Monday.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Related Shares

More News

3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

26 Apr 2024 13:36

UK dividends calendar - next 7 days

25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth readi...

25 Apr 2024 10:15

Hikma Pharmaceuticals backs outlook after making strong start to 2024

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported an encouraging start to the year supported by all three business segments.

25 Apr 2024 08:01

Hikma delivers strong Q1, holds on to guidance

(Sharecast News) - Pharmaceuticals group Hikma said it has made a "strong and encouraging start" to 2024, with all three business segments performing ...